Magnesium sulphate has previously been shown therapeutic in porcine malignant hyperthermia. It was given intravenously in doses of 99 mg. kg -~ before and 277 mg-kg -~ after an episode of malignant hyperthermia had been produced by halothane 1.5 per cent, in agroup of four malignant hyperthermia susceptible swine. Two groups of four additional MH susceptible and MH resistant swine received a constanl infusion of magnesium sulphate 10 mg. kg -~ until approximately 95 per cent depression of foretoe twitch was produced. Four hyperthermia susceptible controls received saline infusions. All were then immediately challenged with succinylcholine 2 rag. kg -t and halothane 1.5 per cent. Muscle strips from three other malignant hyperthermia swine were exposed in vitro to magnesium sulphate with and without halothane, and response of twitch tension and contracture were measured. The malignant hyperthermia response to halothane 1.5 per cent was attenuated but not prevented by pretreatment with magnesium sulphate. It did not appear to be therapeutic in this group. Depression of toe twitch by magnesium sulphate was similar in MH susceptible and MH resistant pigs. Pretreatment wilh magnesium sulphate markedly attentuated the response to a succinylcholine-halothane challenge in MH susceptible pigs. In vitro magnesium sulphate depressed twitch and halothane coutracture responses. We conclude that magnesium sulphate is partially prophylactic for the malignant hyperthermia challenge. The mechanism of this response is likely secondary to calcium ion antagonism at multiple sites. The muscle relaxant reponse to magnesium sulphate cannot be used as a diagnostic test for porcine malignant hyperthermia.
INTRAVENOUS MAGNESIUM ION has been shown to be of therapeutic benefit in established porcine malignant hyperthermia (MH).I'2 The aetiology of MH is unknown but may involve abnormal calcium ion metabolism in skeletal muscle. 3 Magnesium ion can antagonize physiological events mediated by calcium ion. This study evaluates the effect of intravenous magnesium sulphate on the response to malignant hyperthermia challenge by anaesthesia and on the already established MH syndrome. Response of foretoe twitch tension depression to intravenous magnesium sulphate in malignant hyperthermia susceptible (MHS) and malignant hyperthermia resistant (MHR) swine was evaluated. The effects of increased magnesium sulphate concentration on basal twitch and contracture response to halothane of muscle strips obtained from malignant hyperthermia susceptible animals were also measured in vilro.
METHODS AND MATERIALS
The experimcntal animals were pure-bred Po- land China malignant hyperthermia susceptible (MHS) or Hampshire malignant hyperthermia resistant (MHR) swine. Susceptibility was established by first subjecting each animal to in vitro caffeine-halothane contracture testing. 4 Anaesthesia was induced and maintained in all experiments with thiopentone 2.5 per cent, in a dose sufficient to allow orotracheal intubation and to obtund limb movement when halothane was not being added. Oxygen 4 litres, min -t was provided through a semi-closed circle carbon dioxide absorption breathing circuit. Ventilation was assisted or controlled with a Bird Mark 4A ventilator. Peak expired carbon dioxide and halothane concentrations were monitored by continuous sampling from the exhalation hose. Rectal temperature was also monitored continuously. Fluids and thiopentone were administered through an ear vein catheter. Arte.rial pressure was measured by transducer and recorded from an ear artery. Magnesium sulphate was administered through an anterior vena cava catheter and blood was sampled for magnesium from the arterial line. Foretoe twitch tension (indirectly stimulated) was transduced and recorded as previously described, s Resting tension was 100 g. Lactated Ringer's solution 5 ml. kg -t was infused during all experimental procedures. 363
Magnesium -Incremental in this series, in which magnesium sulphate was given incrementally by bolus, four MHS litter mates of either sex were submitted to two experiments: first, to examine the effect of intravenous magnesium sulphate on a subsequent MH challenge and second, one week later, to evaluate the effect of intravenous magnesium sulphate on an established episode of malignant hyperlhermia. For the first procedure, the mean weight of the animals was 25.2. kg (+ 1 SE). After stable thiopentone anaesthesia had been achieved and monitoring devices attached, 50 per cent magnesium sulphate was injected intravenously in 100 mg bolus increments every two minutes to a total dose of 2.5 g. One gram of magnesium sulphate equals two millimoles or 8.12 milliequivalents of magnesium ion. Two minutes after the last increment of magnesium sulphate, halothane 1.5 per cent was introduced into the breathing circuit. Once peak expired concentration had reached 0.8 per cent, the vaporizer output was reduced to maintain this level. Halothane was discontinued when the malignant hyperthermia syndrome was diagnosed by observing hind limb extensor rigidity, abnormal elevations in peak expired carbon dioxide and increasing rectal temperature. Spontaneous ventilation was allowed during these procedures.
For the second procedure, the mean weight of the animals was 26.3 kg (+ 1 SE). After stabilization of the monitored parameters, halothane was introduced as before. The MH syndrome was allowed to become clearly established by observing hind limb rigidity, marked elevation in peak expired carbon dioxide, rapidly increasing rectal temperature, and cardiac arrhythmia; then 50 per cent magnesium sulphate was administered as intravenous bolus doses of 500 mg every I to 2 minutes to a cumulative dose of 7.5 g. Halothane was then discontinued. Ventilation was supported mechanically when malignant hyperthermia was diagnosed. If a favourable therapeutic response on the monitored parameters was not observed within five minutes of the last magnesium sulphate, dantrolene sodium 1.0 rag. ml -~ was given intravenously in increments of 1.5 mg-kg -l along with sodium bicarbonate and surface cooling by ice, if needed, until the episode of malignant hyperthermia was reversed.
Magnesium -Infusion
In the series in which magnesium sulphate was infused, four MHS and four MHR swine were used and infused to near maximum twitch de-CANADIAN ANAESTHETISTS' SOCIETY JOURNAL pression, while another four MHS swine were given only a saline infusion. All then received a st, ccinylcholine-halothane challenge. Animals from three MHS litters were t, sed and at least one animal from each litter was in each group. Anaesthesia was induced and maintained with thiopentone and measurements were made as in the previous series.
Magnesium sulphate 50 per cent was diluted in sterile water so that, using an infusion pump at a constant rate of l0 ml. rain -~, the animals would receive l0 mg.kg -~. rain -~ of drug. The MHS animals on saline infusion received an equivalent volume over the same time period. Spontaneous respiration was allowed during infusion. Infusion was stopped when nearly complete twitch depression was observed. All animals were then immediately given intravenous succinylcholine 2 mg.kg -~, halothane 1.5 cent was introduced simultaneously into the breathing circuit and mechanical ventilation was instituted. Vaporizer output was adjusted to maintain peak exhaled halothane at 0.8 per cent. Ventilation rate was adjusted in an attempt to maintain pre-challenge peak exhaled carbon dioxide.
Halothane was discontinued when the malignant hyperthermia syndrome became evident by observing hind limb extensor rigidity, rectal temperature 39 ~ C, arterial cH + 63.10 nmol/I (pH 7.2), and rapidly increasing peak expired carbon dioxide. Hyperventilation was continued but no other therapy was administered.
Arterial magnesium levels were determined in all groups before infusion, and after infusion in those animals which had been given magnesium sulphate. All animals received infusion of lactated Ringer's solution 5 ml. kg -t .hr -~. during the procedures. Experiments were carried out in an air-conditioned environment at 22 ~ C. Animals had been fasted since the preceding evening, but had been allowed water. Humane standards of management were observed consistent with those recommended by the American Physiological Society.
Magnesium -In vitro
Muscle strips were obtained from gracilis muscle of three other Poland China MHS pigs. 6 Each muscle strip was fixed in a chamber containing 100 ml of Kreb's Ringer solution (magnesium ion 1.2 mmol/l) maintained at 37 ~ C. A mixture of 95 per cent-oxygen and five per cent carbon dioxide was bubbled continuously through the muscle bath. A resting tension of 2 g was placed on each strip and this tension and the contractile twitch force were measured continuously by a force transducer and recorded. Muscle twitch was induced by stimulating each strip directly with supramaximal voltage of one msec duration and a frequency of one stimulus every 10 seconds. After the twitch had stabilized, aliquots of a stock magnesium sulphate solution were added to the muscle bath and the effects on basal twitch and subsequent exposure to three per cent halothane were measured.
Results are reported as mean +_ SE. Student's t-test for paired data was used for within and between groups. Significance was assumed at the p 0.05 level.
RESULTS
All animals developed malignant hyperthermia after each halothane exposure in the magnesium sulphate bolus series. The episode was significantly attenuated by the prophylactic administration or magnesium sulphate. Before the first challenge magnesium sulphate 99 mg. kg -~ (+4 SE) produced 10 per cent (__+1 SE) twitch depression when given over 47 rain (+ I SE) with no significant change in arterial blood pressure, peak exhaled carbon dioxide or rectal temperature ( Figure 1 ). Halothane was administered for 44 minutes (-I-7 SE) (range 30-60) before malignant hyperthermia was diagnosed and anaesthesia discontinued. All animals recovered without complication and were given no therapy.
Initial levels for arterial pressure, peak exhaled carbon dioxide and rectal temperature did not differ between the experiments, with or without previous exposure to magnesium sulphate; but without magnesium sulphate peak exhaled carbon dioxide and rectal temperature were significantly higher after 30 minutes than in the previous exposure (Figure 1 ). Magnesium sulphate was withheld until the episode of malignant hyperthermia had become fulminant after 50 minutes (-I-14 SE) of exposure to halothane. Then magnesium sulphate 277 mg-kg ' (4-10 SE), was given over 12.5 (+2 SE) minutes. This produced a twitch depression of 24 per cent (+7 SE). While infusion was progressing, rectal temperature and peak exhaled carbon dioxide continued to increase and arterial blood pressure decreased significantly (Figure 1) . Magnesium appeared to have no therapeutic effect on malignant hyperthermia. In contrast, dantrolene produced an immediate favourable response: peak exhaled carbon dioxide fell rapidly, arterial pressure began to increase and the rate of temperature rise was blunted. In two subjects dantrolene 1.5 mg.kg -~ alone was needed for successful therapy. In two others, dantrolene 3.0 and 4.5 rag. kg-', sodium bicarbonate 4 rag. kg-', and surface cooling with ice were required to reverse the malignant hyperthermia. All animals survived. Arterial magnesium was measured in two animals: control levels were 0.75 and 0.9 mmol/l which increased to 7.3 and 8.1 mmolJl respectively after administration of magnesium sulphate.
The effect of magnesium sulphate infusion on foretoe twitch depression is shown in Figure 2 . No significant difference was observed beween mean responses at any infused dose, whether administered to MHS or MHR animals. Peak twitch depression and cumulative magnesium sulphate dose infused did not differ (Table I) . No twitch depression was observed in animals infused with saline. The pre-infusion arterial magnesium levels were similar. Magnesium levels post-infusion and changes in levels between MHS and MHR groups did not differ (Table I) . Systolic blood pressure was significantly reduced by magnesium in both groups, while heart rate remained unchanged (Table I) (Table I) . Arterial hydrogen ion changed significantly in both MHS groups (Table I) . Rectal temperature was unchanged in all groups during infusion.
All MHS animals developed malignant hyperthermia when challenged. The saline group had a much more fulminant course and all expired between 50-60 minutes after challenge. In contrast, only two of four MHS animals which had been given magnesium sulphate died, at 63 and 86 minutes respectively. Malignant hyperthermia was diagnosed and halothane discontinued after only 9.5 minutes -I-1.3 SE in the saline group but not until after 36 minutes +7 SE in the group infused with magnesium sulphate; a highly significant difference (p < .005). There was no difference between the MHS groups for peak expired carbon dioxide, arterial pressure, rectal temperature, or arterial hydrogen ion before administration of the succinylcholine-halothane challenge (Figure 3 ). Ten minutes after start of the challenge MHS pigs infused with saline had significantly higher peak exhaled carbon dioxide, rectal temperature and arterial hydrogen ion concentrations, and these differences were even greater at 40 minutes (Figure 3 ). No differences in systolic blood pressure were observed at 10 and 40 minutes, however, as the saline animals were showing a progressive decline in pressure before death (Figure 3) .
The percentage twitch blocked by in vitro magnesium was variable under the present experimental conditions (Table II) . There is no doubt that magnesium significantly depressed twitch response in each muscle strip. However, increasing concentration of magnesium did not always produce a proportionate depression of twitch. It appears that a maximum twitch depression of about 30 per cent occurs at a magnesium concentration of 7.5 mmol/l (Table II) .
The contracture response of MHS muscle to three per cent halothanc was markedly depressed by magnesium. At a final magnesium concentration of 8.7 mmol/I contracture was 80 per cent lower than that observed in the absence of magnesium (Table II) . DISCUSSION The intravenous administration of magnesium sulphate as prophylaxis against a halothane or succinylcholine-halothane challenge attenuated but did not prevent malignant hyperthermia. In the magnesium sulphate infusion series, saline treated controls had a much more rapid onset of clinical malignant hyperthe rmia (9.5 minutes) and fulminant progression resulting in 100 per cent mortality, in contrast, the prophylactic administration of magnesium sulphate 260 mg-kg t delayed the onset of clinical malignant hyperthermia (36 minutes), the development of acidosis was obtunded and only two of four animals died. The arterial magnesium level achieved with this dose was 4.5. mmol/l, and it did not depress cardiovascular function. We did not observe a specific therapeutic response to magnesium sulphate 277 mg.kg-', given concurrently with halothane. The level of 7.5 mmol/I magnesium achieved in arterial blood might have been depressant to the cardiovascular system and, therefore, detrimental to the animals. Perhaps a mote favourable response would have resulted if halothane had been discontinued before magnesium sulphate therapy.
Lister ~ has reported a therapeutic response to thyroxine and 5-6 mmol/l of magnesium sulphate in venous blood for succinylcholine-induced malignant hyperthermia. Hall, et al.,2 observed a therapeutic response to intravenous magnesium sulphate 240 mg.kg -t in halothane-induced malignant hyperthermia. Doses employed produced venous magnesium levels of 9 mmol/l. Larger doses of 700 mg. kg -t produced cardiac arrest in some animals when venous magnesium levels exceeded 10 mmol/I. We had hoped to observe a significant difference between MHS and MHR animals in twitch depression produced by magnesium sulphate, which might serve as a diagnostic test for malignant hyperthermia. No difference in the magnesium sulphate dose response was observed between these groups (Figure 2) .
Although the aetiology of malignant hyperthermia has not been determined, most evidence supports a primary myogenic aetiology. Evidence for lesions of several other tissues has been reviewed by Rosenberg) We speculate that any process that produces firing of motor nerve terminals or stimulates skeletal muscle directly might be detrimental to individuals susceptible to the syndrome. Conversely, processes which depress terminal firing or skeletal muscle function directly should be beneficial.
By what mechanism does magnesium exert its beneficial effect in malignant hyperthermia? Magnesium ion is antagonistic to calcium in many physiological processes. Magnesium blocks neuromuscular transmission by decreasing the calcium-mediated liberation of acetylchollne from synaptic terminals) The neuromuscular block produced by constant magnesium sulphate infusion was very transient in our study and twitch depression reversed rapidly when infusion was terminated. Perhaps continuous infusion sufficient to maintain a high degree of blockade would have produced a greater prophylactic effect. Hall, et at., s reported that preliminary tubocurarine blockade of skeletal muscle prevented porcine malignant hyperthermia stimulated by succinylcholine. Pancuronium-induced blockade attenuated but did not prevent MH induced by halothane in the same study. Halothane is thought to produce malignant hyperthermia by an intracellular mechanism: Sair, et al. 9 gave curare and magnesium sulphate before slaughter of MHS swine. Curare attenuated and magnesium sulphate prevented skeletal muscle depletion of creatine phosphate energy stores and the development of pale, soft exudative skeletal muscle typical of malignant hyperthermia. These investigations support the thesis that blockade of the neuromuscular junction and resulting decrease in skeletal muscle stimulation is efficacious in malignant hyperthermia.
Increases in serum magnesium cause depression of catecholamine release from the adrenal medulla, which is a calcium dependent process, t0 Epinephrine has a direct effect on mammalian skeletal muscle mediated through beta receptors, stimulating fast and depressing slow contracting fibers: Epinephrine also stimulates neuromuscular transmission in both fast and slow skeletal muscle, mediated through alpha receptors by stimulating acetylcholine release.tt Phentolamine alpha blockade has been shown prophylactic but not therapeutic in porcine malignant hyperthermia and propranolol beta blockade was not therapeutic in porcine malignant hyperthermia. J2 Magnesium produces sympathetic ganglion block with resulting peripheral vasodilation, ~3 a process which promotes heat loss.
The in vitro results, that is depression in twilch tension and diminution of halothane contracture response by magnesium, support the conclusion that, overall, magnesium muscle relaxant effect and the prophylactic response by magnesium sulphate in halotbane-induced malignant hypthermia in vivo are due in part to direct cellular (probably intracellular) mechanisms in skeletal muscle.
In conclusion, intravenous magnesium sulphate effectively attenuated but did not prevent malignant hyperthermia induced by succinylcholine and halothane in swine. Magnesium may also have a therapeutic role in established malignant hyperthermia, but caution should be exercised during administration to avoid cardiovascular depression. The mechanism of the magnesium effect is likely multifactorial through depression of neuro-muscular transmission, direct skeletal muscle relaxation, depression of catecholamine activity and promotion of heat loss, all involving antagonism of calcium ion activity. The skeletal muscle relaxant response to intravenous magnesium is similar in MH susceptible and MH resistant animals, precluding this response as a diagnostic test of susceptibility to malignant hyperthermia.
